Diabetes is a disorder of glucose regulation, which is performed by an accumulating of
glucose concentration in the blood. Although it is a chronic disease, it threatens human …

A number of lipid-based technologies have been applied to pharmaceuticals to modify their
drug release characteristics, and additionally, to improve the drug loading for poorly soluble …

Nanomedicine is defined as the application of nanobiotechnology to medicine. It is a
discipline at the interface of medicine and nanobiotechnology but is not a subspecialty of …

Introduction: A number of delivery issues exist for biotech molecules including peptides,
proteins and gene-based medicines that now make up over 60% of the drug pipeline. The …

The increasing rate of resistance of bacterial infection against antibiotics requires next
generation approaches to fight potential pandemic spread. The development of vaccines …

The controlled delivery of therapeutics in a manner responsive to physiological indicators
has promise in realizing new therapeutic approaches to combat disease. This approach is …

Lectins are carbohydrate recognizing proteins originating from diverse origins in nature,
including animals, plants, viruses, bacteria and fungus. Due to their exceptional glycan …

With diabetes mellitus becoming an important public health concern, insulin‐delivery
systems are attracting increasing interest from both scientific and technological researchers …

Diabetes mellitus has become one of the biggest medical challenges affecting millions of
people globally. Alternative treatments for diabetes are currently being intensively …

Peptides and therapeutic proteins have been the target of intense research and
development in recent years by the pharmaceutical and biotechnology industry. Preferably …